Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Mizuguchi

Showing results (31-40 of 406) with videos related to

Pageof 41
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 2, 2013
[Development of an adenovirus vector containing a hepatitis C virus expression cassette and its application]Takeshi Yoshida, Masuo Kondoh, Hiroyuki Mizuguchi, et al.
Anticancer Research|January 31, 2021
Optimization of an E1A Gene Expression Cassette in an Oncolytic Adenovirus for Efficient Tumor Cell Killing ActivityFuminori Sakurai, Fumitaka Nishimae, Kosuke Takayama, et al.
Frontiers in Pharmacology|June 15, 2026
Hepatic lipid quantity and quality in type 2 diabetes mellitusKahori Shimizu, Hideo Shindou, Koji Tomita, et al.
Biochemical and Biophysical Research Communications|February 8, 2018
Billion-scale production of hepatocyte-like cells from human induced pluripotent stem cellsTomoki Yamashita, Kazuo Takayama, Fuminori Sakurai, et al.
Molecular Therapy Oncolytics|February 22, 2021
Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35Ryosuke Ono, Kosuke Takayama, Fuminori Sakurai, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 5, 2012
[Development of a novel adenovirus vector exhibiting microRNA-mediated suppression of the leaky expression of adenovirus genes]Kahori Shimizu, Fuminori Sakurai, Masashi Tachibana, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 24, 2008
Efficient gene delivery in human and rodent mast cells using adenovirus vectorsKazuko Nakashima, Fuminori Sakurai, Kenji Kawabata, et al.
Anticancer Research|April 12, 2012
Correlation between adenovirus-neutralizing antibody titer and adenovirus vector-mediated transduction efficiency following intratumoral injectionKyoko Tomita, Fuminori Sakurai, Masashi Tachibana, et al.
Journal of Pharmacological Sciences|February 26, 2020
Inverse Agonistic Activity of Antihistamines and Suppression of Histamine H<sub>1</sub> Receptor Gene ExpressionHiroyuki Mizuguchi, Shohei Ono, Masashi Hattori, et al.
Biological & Pharmaceutical Bulletin|July 23, 2002
Comparison of the efficiency and safety of non-viral vector-mediated gene transfer into a wide range of human cellsEriko Uchida, Hiroyuki Mizuguchi, Akiko Ishii-Watabe, et al.
Pageof 41

Showing results (31-40 of 406) with videos related to

Sort By:
Pageof 41
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 2, 2013
[Development of an adenovirus vector containing a hepatitis C virus expression cassette and its application]Takeshi Yoshida, Masuo Kondoh, Hiroyuki Mizuguchi, et al.
Anticancer Research|January 31, 2021
Optimization of an E1A Gene Expression Cassette in an Oncolytic Adenovirus for Efficient Tumor Cell Killing ActivityFuminori Sakurai, Fumitaka Nishimae, Kosuke Takayama, et al.
Frontiers in Pharmacology|June 15, 2026
Hepatic lipid quantity and quality in type 2 diabetes mellitusKahori Shimizu, Hideo Shindou, Koji Tomita, et al.
Biochemical and Biophysical Research Communications|February 8, 2018
Billion-scale production of hepatocyte-like cells from human induced pluripotent stem cellsTomoki Yamashita, Kazuo Takayama, Fuminori Sakurai, et al.
Molecular Therapy Oncolytics|February 22, 2021
Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35Ryosuke Ono, Kosuke Takayama, Fuminori Sakurai, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 5, 2012
[Development of a novel adenovirus vector exhibiting microRNA-mediated suppression of the leaky expression of adenovirus genes]Kahori Shimizu, Fuminori Sakurai, Masashi Tachibana, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 24, 2008
Efficient gene delivery in human and rodent mast cells using adenovirus vectorsKazuko Nakashima, Fuminori Sakurai, Kenji Kawabata, et al.
Anticancer Research|April 12, 2012
Correlation between adenovirus-neutralizing antibody titer and adenovirus vector-mediated transduction efficiency following intratumoral injectionKyoko Tomita, Fuminori Sakurai, Masashi Tachibana, et al.
Journal of Pharmacological Sciences|February 26, 2020
Inverse Agonistic Activity of Antihistamines and Suppression of Histamine H<sub>1</sub> Receptor Gene ExpressionHiroyuki Mizuguchi, Shohei Ono, Masashi Hattori, et al.
Biological & Pharmaceutical Bulletin|July 23, 2002
Comparison of the efficiency and safety of non-viral vector-mediated gene transfer into a wide range of human cellsEriko Uchida, Hiroyuki Mizuguchi, Akiko Ishii-Watabe, et al.
Pageof 41